GlycArt Biotechnology's Seed Round

GlycArt Biotechnology raised a round of funding on January 01, 2001.

GlycArt is a Swiss biotechnology company focused on the development and commercialization of a new generation of antibody products based on its proprietary GlycoMAb technology. GlycoMAb has the potent…

Articles about GlycArt Biotechnology's Seed Round: